| Title: | Serum uric acid and the trajectory of cardiometabolic multimorbidity: a prospective study conducted with data from the UK Biobank |
| Journal: | Nutrition Journal |
| Published: | 30 Apr 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/42063047/ |
| DOI: | https://doi.org/10.1186/s12937-026-01324-8 |
| URL: | http://dx.doi.org/10.1186/s12937-026-01324-8 |
Publication 17794
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
ObjectiveThis study aimed to investigate the role of serum uric acid (SUA) in disease progression from baseline to first cardiometabolic disease (FCMD), subsequent cardiometabolic multimorbidity (CMM), and mortality.MethodsWe conducted a prospective analysis using UK Biobank data (n = 418,765). CMM was defined as the coexistence of at least at least two cardiometabolic conditions out of type 2 diabetes (T2D), ischemic heart disease (IHD), and stroke. Multi-state models were employed to analyze the associations between SUA levels and disease transitions across different stages, including disease-specific analyses for individual cardiometabolic diseases.ResultsDuring follow-up, 54,946 participants developed FCMD, of whom 6,260 progressed to CMM. Each 1 mg/dL increase in SUA was associated with higher risks of FCMD [HR: 1.08 (1.07, 1.09)], transition from FCMD to CMM [HR: 1.07 (1.05, 1.10)], and all-cause mortality from all states [HR 1.04 (1.03, 1.05) from baseline to death; HR 1.03 (1.01, 1.05) from FCMD to death; HR 1.08 (1.03, 1.12) from CMM to death]. When FCMD was further divided into IHD, stroke, and T2D, we found that SUA played different roles in disease-specific transitions even within the same stage, with the strongest associations observed for incident T2D [HR: 1.15 (1.14, 1.17)] and stroke-to-CMM progression [HR: 1.11 (1.04, 1.18)]. These associations remained robust across sensitivity analyses and were stronger in younger participants (< 60 years).ConclusionsElevated SUA levels serve as a potential marker across the entire trajectory of cardiometabolic disease progression. These findings suggest the importance of SUA monitoring and management in preventing cardiometabolic disease progression.</p>
7 Authors
- Juan Wu
- Yingdong Han
- Menghui Yao
- Zhikai Li
- Tiange Xie
- Yun Zhang
- Xuejun Zeng
1 Application
| Application ID | Title |
|---|---|
| 479734 | Correlation and causal relationship of Blood lipids and metabolites, healthy lifestyle and socioeconomic status with prevalence and mortality of metabolic disease. |
Enabling scientific discoveries that improve human health